Diffusion and perfusion magnetic resonance imaging in newly diagnosed glioblastoma following treatment with Bevacizumab, Temozolomide and hypo-fractionated stereotactic radiotherapy (HFSRT) Meeting Abstract


Authors: Daras, M.; Karimi, S.; Abrey, L.; Sanchez, J.; Beal, K.; Gutin, P.; Kaley, T.; Grommes, C.; Correa, D.; Reiner, A.; Briggs, S.; Omuro, A.
Abstract Title: Diffusion and perfusion magnetic resonance imaging in newly diagnosed glioblastoma following treatment with Bevacizumab, Temozolomide and hypo-fractionated stereotactic radiotherapy (HFSRT)
Meeting Title: 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)/18th Annual Meeting of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 15
Issue: Suppl. 3
Meeting Dates: 2013 Nov 21-24
Meeting Location: San Francisco, CA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2013-11-01
Start Page: iii194
Language: English
ACCESSION: WOS:000327456200759
PROVIDER: wos
DOI: 10.1093/neuonc/not189
PMCID: PMC3823904
Notes: Meeting Abstract: RA-013 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anne S Reiner
    248 Reiner
  2. Denise D Correa
    83 Correa
  3. Philip H Gutin
    163 Gutin
  4. Antonio Marcilio Padula Omuro
    204 Omuro
  5. Kathryn Beal
    221 Beal
  6. Sasan Karimi
    114 Karimi
  7. Thomas Kaley
    154 Kaley
  8. Christian Grommes
    150 Grommes
  9. Lauren E Abrey
    278 Abrey
  10. Mariza Daras
    27 Daras
  11. Samuel Royden Briggs
    18 Briggs